What should be included in the evaluation of Wolff-Parkinson-White (WPW) syndrome?

Updated: Jan 08, 2017
  • Author: Christopher R Ellis, MD, FACC, FHRS; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print

Evaluate patients with WPW syndrome for the presence of very short refractory periods, because these patients carry higher probabilities of developing symptoms or complications. The patients also respond poorly to drug therapy. Identify these patients, even if asymptomatic, and treat them aggressively using electrophysiologic study (EPS) and ablative therapy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!